Cell specific mitochondria targeted metabolic alteration for precision medicine

Area of Science:

• Biomedical Engineering
• Cancer Biology
• Nanotechnology

Background:

• Mitochondria are crucial for cellular health but undergo significant alterations in cancer, promoting tumor growth and therapeutic resistance.
• Targeting mitochondria offers a promising strategy for cancer control by addressing these altered cellular functions.
• Targeted cancer medicine has advanced, enabling specific delivery of therapeutics to mitochondria.

Purpose of the Study:

• To develop a feasible method for specifically targeting prostate cancer cell mitochondria.
• To demonstrate the delivery of a chemotherapeutic prodrug to mitochondria for enhanced cancer therapy.
• To create repair-resistant adducts within mitochondrial DNA to induce cancer cell death.

Main Methods:

• Constructed a single blended nanoparticle (NP) using two functionalized polymers for dual targeting.
• Designed a polymeric platform with variations in amphiphilic portions and linkers for optimized targeting.
• Utilized analytical and in vitro studies to demonstrate the proof-of-concept and efficacy of the NP design.

Main Results:

• Achieved prostate cancer-specific mitochondrial delivery of a chemotherapeutic prodrug.
• Demonstrated the creation of repair-resistant adducts within mitochondrial DNA, leading to cellular death.
• Optimized blended NPs for effective and specific mitochondrial targeting in cancer cells.

Conclusions:

• Developed a novel nanoparticle-based strategy for targeted mitochondrial delivery in prostate cancer.
• This approach shows potential for overcoming therapeutic resistance by inducing mitochondrial DNA damage.
• The study validates a proof-of-concept for dual-targeted, mitochondria-disrupting cancer therapy.